Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tiny bacteria, big impact on IVF? new study investigates

NCT ID NCT07187414

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study examined bacteria in sperm and follicular fluid from 50 couples undergoing IVF. Researchers identified and counted the bacteria to see if they influence fertilization and embryo development. The goal is to understand whether these microbes play a role in IVF success rates.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If bacteria in sperm or follicular fluid are linked to IVF success, this could lead to better screening or treatments to improve fertility outcomes.
What could go wrong
This is a small, observational study with only 50 participants. It describes bacteria but does not test any treatment, so it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

50 people

The number who actually took part.

Started

Jan 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Collection of data from medical records and analysis of biological samples taken from couples as part of medically assisted procreation care.

Ages

18 to 59 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Man aged 18 to 59 who have provided a sperm sample after an abstinence period of between 2 and 7 days. Sperm prepared by density gradient on day 0. Negative sperm culture (\<6 months). No specific urogenital history (varicocele, cryptorchidism, testicular ectopia, etc.). * Women aged 18 to 43 undergoing oocyte puncture with collection of follicular fluid on day 0. No endometriosis or hydrosalpinx. Negative vaginal sample (\< 6 months). * Negative HIV, HBV, and HCV serology tests within the last year. * Absence of urinary tract infections in men and sexually transmitted infections (HPV, HSV, HIV-1/2, C. trachomatis, Gonorrhea, Syphilis, etc.) (\<6 months). * Absence of recent antibiotic or antifungal treatment (end of treatment \< 3 months) Absence of probiotic intake (\< 3 months). * No history of chemotherapy or radiation therapy. * Embryonic culture performed up to day 6 for all zygotes. Exclusion Criteria: * Homosexual patient couples or transsexual couples * Patients treated for medically assisted procreation with a third-party donor * Frozen sperm pellets (ejaculate or surgical) * Donor sperm * Sperm prepared by washing * Abstinence period \<2 or \>7 days * Fever \<3 months * History of chemotherapy or radiotherapy. * History of urinary tract infections in man (\< 6 months) * History of sexually transmitted infections (HPV, HSV, HIV-1/2, C. trachomatis, gonorrhea, syphilis, etc.) (\<6 months) * Specific urogenital history (varicocele, cryptorchidism, testicular ectopia, etc.) * Recent antibiotic therapy or antifungal treatment (end of treatment \< 3 months) * Taking probiotics (end of treatment \< 3 months) * Positive sperm culture \< 6 months. * Positive vaginal sample \< 6 months. White puncture. * Collection failure. * Fertilization failure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for In vitro fertilization (IVF) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Privé de Parly II

    Le Chesnay, 78150, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.